Search results for "Bioinformatic"

showing 10 items of 1651 documents

Ad-Hoc Segmentation Pipeline for Microarray Image Analysis

2006

Microarray is a new class of biotechnologies able to help biologist researches to extrapolate new knowledge from biological experiments. Image Analysis is devoted to extrapolate, process and visualize image information. For this reason it has found application also in Microarray, where it is a crucial step of this technology (e.g. segmentation). In this paper we describe MISP (Microarray Image Segmentation Pipeline), a new segmentation pipeline for Microarray Image Analysis. The pipeline uses a recent segmentation algorithm based on statistical analysis coupled with K-Means algorithm. The Spot masks produced by MISP are used to determinate spots information and quality measures. A software …

Segmentation-based object categorizationComputer scienceScale-space segmentationSegmentationImage processingImage segmentationData miningcomputer.software_genrePipeline (software)computerImage Analysis Microarray Image Segmentation BioinformaticsVisualization
researchProduct

Tranexamic acid for trauma

2010

Selection biasText miningbusiness.industrymedia_common.quotation_subjectMEDLINEmedicineGeneral MedicinebusinessBioinformaticsTranexamic acidmedia_commonmedicine.drugThe Lancet
researchProduct

The risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators.

2006

Cardiovascular disease, a generic denomination including coronary heart disease (CHD), stroke, and venous thromboembolic disease (VTED), has shown sensitivity to estrogens. The relative protection of women as compared with men has nourished a debate about a possible protective role for estrogens, but the prejudicial effects detected in clinical trials has created confusion on the risk/benefit ratio induced by hormone administration. The hypothesis that agonists distinct to estrogens might improve the effects associated with estrogens is at the base of the increasing interest on the role of selective estrogen receptor modulators (SERMs). There is a lack of definitive clearcut clinical data o…

Selective Estrogen Receptor ModulatorsCoronary DiseaseDiseaseBioinformaticsVenous thromboembolic diseaseSex FactorsRisk FactorsThromboembolismMedicineAnimalsHumansStrokeVenous Thrombosisbusiness.industryEstrogensmedicine.diseasePresent momentRatsClinical trialStrokeSelective estrogen receptor modulatorCardiovascular DiseasesWomen's HealthFemalebusinessVenous diseasehormones hormone substitutes and hormone antagonistsHormoneFrontiers in bioscience : a journal and virtual library
researchProduct

Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Age…

2010

Nowadays, people are living much longer than they used to do, however they are not free from ageing. Ageing, an inexorable intrinsic process that affects all cells, tissues, organs and individuals, is a post-maturational process that, due to a diminished homeostasis and increased organism frailty, causes a reduction of the response to environmental stimuli and, in general, is associated to an increased predisposition to illness and death. However, the high incidence of death due to infectious, cardiovascular and cancer diseases underlies a common feature in these pathologies that is represented by dysregulation of both instructive and innate immunity. Several studies show that a low-grade s…

SenescenceAgingPathologymedicine.medical_specialtyAgeing age-related diseases diet drug inflammation longevity.LongevityPopulationInflammationDiseaseBioinformaticsSystemic inflammationDrug Delivery SystemsDegenerative diseaseDrug DiscoveryAnimalsHumansMedicineeducationInflammationPharmacologyeducation.field_of_studyInnate immune systemDose-Response Relationship Drugbusiness.industrymedicine.diseasePharmaceutical PreparationsAgeingInflammation Mediatorsmedicine.symptombusiness
researchProduct

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers.

2019

The prevalence of several diseases increases by age, including cardiovascular diseases, which are the leading cause of morbidity and mortality worldwide. Aging, as a complex process characterized by senescence, triggers various pathways, such as oxidative stress, systemic inflammation, metabolism dysfunction, telomere shortening, mitochondrial dysfunction and deregulated autophagy. A better understanding of the mechanisms underlying senescence may lead to the development of new therapeutic targets and strategies for age-related pathologies and extend the healthy lifespan. Modulating lifestyle risk factors and adopting healthy dietary patterns remain significant tools in delaying the aging …

SenescenceAgingmedia_common.quotation_subjectCardioprotectionDisease030204 cardiovascular system & hematologyDiabeteBioinformaticsSystemic inflammation03 medical and health sciences0302 clinical medicineRisk FactorsCardiovascular DiseaseDiabetes mellitusDrug DiscoveryMedicineHumansLife Style030304 developmental biologymedia_commonPharmacologyCardioprotection0303 health sciencesbusiness.industryRisk FactorLongevityCardiovascular riskmedicine.diseaseMetabolic syndromeDietCardiovascular DiseasesLife expectancyQuality of LifeNutraceuticalMetabolic syndromemedicine.symptombusinessHumanCurrent pharmaceutical design
researchProduct

SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence

2021

Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) has increased substantially in medical practice due to their documented benefits in cardiorenal and metabolic health. In this sense, and in addition to being used for glycemic control in diabetic patients, these drugs also have other favorable effects such as weight loss and lowering blood pressure, and more recently, they have been shown to have cardio and renoprotective effects with anti-inflammatory properties. Concerning the latter, the individual or associated use of these antihyperglycemic agents has been linked with a decrease in p…

SenescenceEndocrinology Diabetes and MetabolismAdipose tissueInflammationGlycemic ControlReview ArticleDiseaseBioinformaticsDiseases of the endocrine glands. Clinical endocrinologyGlucagon-Like Peptide-1 ReceptorProinflammatory cytokineEndocrinologySodium-glucose cotransporter 2 inhibitors (SGLT2i)Weight lossDiabetes mellitusmedicineHumansSodium-Glucose Transporter 2 InhibitorsCellular SenescenceGlycemicInflammationMetabolic SyndromeManagement of diabetesRonyonsDiabetisbusiness.industryRC648-665medicine.diseaseCor MalaltiesAdipose TissueantihyperglycemicPatients obesity and cardiorenal compromiseglycemic controlmedicine.symptombusinessGlucagon-like peptide 1 receptor agonists (GLP-1RA)
researchProduct

Telomere length and cardiovascular disease

2010

SummaryTelomeres are structures composed of deoxyribonucleic acid repeats that protect the end of chromosomes, but shorten with each cell division. They have been the subject of many studies, particularly in the field of oncology, and more recently their role in the onset, development and prognosis of cardiovascular disease has generated considerable interest. It has already been shown that these structures may deteriorate at the beginning of the atherosclerotic process, in the onset and development of arterial hypertension or during myocardial infarction, in which their length may be a predictor of outcome. As telomere length by its nature is a marker of cell senescence, it is of particula…

SenescenceGenetic Markersmedicine.medical_specialtyCell divisionDiseaseBioinformaticsmedicine.disease_causeTélomèreInternal medicinemedicineAnimalsHumansFacteurs de risque cardiovasculairesMyocytes CardiacMyocardial infarctionRisk factorCellular SenescenceCardiovascular risk factorsMaladies cardiovasculairesbusiness.industryStress oxydatifGeneral MedicineTelomeremedicine.diseaseTelomereEndocrinologyCardiovascular diseasesGene Expression RegulationGenetic markerOxidative stressEndothelium VascularbusinessCardiology and Cardiovascular MedicineOxidative stressArchives of Cardiovascular Diseases
researchProduct

Hsp60 and Hsp10 in Ageing

2009

HSP and molecular chaperones, both referred to in this chapter as chaperones, are key players in development and senescence. With regard to senescence, several issues are critical: the role of normal chaperones in the process of ageing itself and in preventing and controlling age-associated diseases, the role of defective chaperones (chaperonopathies) in the onset and progression of senescence and in the etiology of old-age diseases, the interaction of chaperones with the immune system, and the potential of chaperones as therapeutic agents for counteracting the deleterious effects of ageing on molecules and cells and for treating proteinopathies of the elderly (chaperonotherapy). All these …

Senescencebiologybusiness.industryDiseaseBioinformaticsChaperoninPathogenesisImmune systemAgeingChaperone (protein)biology.proteinMedicinebusinessPathological
researchProduct

Telomeres in the Brain Cortex of Patients with Major Depressive Disorder

2014

Telomeres are complex structures formed by the end of the DNA molecule at the tip of each chromosomal arm. The repeated (TTAGGG) telomeric sequence progressively shortens during lifespan because it cannot be replicated as somatic cells divide, and is highly susceptible to breakage by free radicals. Critically shortened telomeres activate the genetic program of cell senescence and/or apoptosis. The telomere length measured in peripheral blood leucocytes is considered a reliable marker of biological age, mortality risk and exposure to various pathological conditions, including cardiovascular disease, dementia, and metabolic syndrome. Telomere erosion has been observed in psychiatric disorders…

Senescencemedicine.medical_specialtybusiness.industryCognitive NeuroscienceDiseaseBioinformaticsmedicine.diseaseTelomereBehavioral NeurosciencePsychiatry and Mental healthNeurologyMood disordersSchizophreniamedicineMajor depressive disorderNeurology (clinical)businessPsychiatryPathologicalBiological PsychiatryDepression (differential diagnoses)Activitas Nervosa Superior
researchProduct

TRIF turns the switch for DIC in sepsis

2020

SepsisText miningbusiness.industryTRIFImmunologyMedicineCell BiologyHematologybusinessBioinformaticsmedicine.diseaseBiochemistryBlood
researchProduct